2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Saturday, April 29, 2017

5:30pm-7:30pm: Ambiguous Nucleic Acid Tests (NAT) Results – Case of a Donor with Intermittent HCV NAT(+) but No HCV Transmission.

M. Nowicki,^1,2 H. Prince,² C. Chinchilla,² C. De Los Santos,² J. Trageser,³ L. Stocks.³

Poster Session A: Viral Conundrums • Hall D1

5:30pm-7:30pm: An OPO Offer Acceptance Report for Hard-to-Place Kidneys.

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection • Hall D1

5:30pm-7:30pm: Antibiotic Prophylaxis Against Urinary Tract Infections After Renal Transplant.

P. Klem,¹ J. Gralla,² D. Chang,¹ A. Wiseman,² S. Davis,² J. Cooper.²

Poster Session A: Kidney Complications I • Hall D1

5:30pm-7:30pm: Antibody-Mediated Vascular Rejection of Kidney Allografts: What Does It Happen After 15 Years?

B. Rodriguez Cubillo,¹ I. Perez Flores,¹ M. Moreno De La Higuera,¹ M. Calvo,¹ N. Calvo Romero,¹ A. Pascual,² J. Cortes,² J. Blanco,² A. Sanchez-Fructuoso.¹

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I • Hall D1

5:30pm-7:30pm: Antioxidant Thermoresponsive Hydrogel as a Versatile Islets Scaffolds for Treating Type I Diabetes.

Y. Zhu,¹ X. Zhang,² G. Ameer,¹ X. Luo.²

Poster Session A: Cellular & Bone Marrow Transplantation Session I • Hall D1

5:30pm-7:30pm: Antiretroviral Therapy Modification of HIV+ Patients Listed for Kidney Transplantation.

D. Lee,¹ G. Malat,³ T. Bias,¹ S. Epstein,¹ L. Levin Mizrahi,² M. Harhay,² S. Talluri,² K. Ranganna.²

Poster Session A: Viral Conundrums • Hall D1

5:30pm-7:30pm: ASP0113 Elicits an Immune Response in CMV-Seronegative Dialysis Patients: Comparison to Healthy Subjects.

P. Bonate,¹ C. Van Sant,² K. Cho,¹ E. Zook,¹ L. Smith,³ S. Boutsaboualoy, X. Wang,¹ R. Wu,¹ A. Koester,⁴ D. Rammelsberg,⁶ R. Goldwater,⁴ T. Marbury.⁵

Poster Session A: Viral Conundrums • Hall D1

5:30pm-7:30pm: Assessing the Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients After Desensitization (Des) 2 Years Post Implementation.

A. Vo,¹ S. Williamson,¹ K. Myers,¹ E. Huang,¹ J. Choi,¹ X. Zhang,² A. Peng,¹ R. Najjar,¹ S. Jordan.¹

Poster Session A: Clinical Science: Kidney Immunosuppression: Desensitization • Hall D1

5:30pm-7:30pm: Assessment of a Medication Education Program Among New Transplant Recipients at a Large Academic Health Center.

G. Meadows,¹ J. Kyle,¹ A. Dodson,¹ K. Gutierrez,¹ P. MacLennan,² F. Iqbal,² L. Weldon,¹ D. Jones,¹ A. James.¹

Poster Session A: Transplant Economics and Pharmacy Value Initiatives • Hall D1

5:30pm-7:30pm: Assessment of Donor-Reactive T-Cell Immunity by the Novel Urine Cell-Derived Alloantigen Assay Allows Prediction of Acute Rejection in Renal Transplant Patients.

C. Thieme,¹ B. Weist,¹ A. Müskes,¹ P. Reinke,¹ T. Westhoff,² N. Babel.^1,2

Poster Session A: Diagnostics/Biomarkers Session I • Hall D1